reference/13202930

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13202930

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	3258
issn	0041-1345
issueIdentifier	7-8
pageRange	3256-3258
publicationName	Transplantation Proceedings
startingPage	3256
bibliographicCitation	Cho DK, Kim JH, Park SH, Kim JC, Kim CD, Baek MY, Kim SJ, Kim SH, Kwon TH, Kim YL, Kim YW, Chang SK. The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial). Transplant Proc. 2001 Nov;33(7-8):3256–8. doi: 10.1016/s0041-1345(01)02383-1. PMID: 11750394.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_78c0470e8f2b3ca64cb9bd766da5784e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f142cc522abfc07f95648bcb7d9dff8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de03839684ee4a25c275bbb2424a0326 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_213c29296d3417ce2c0bad63d6c82f9c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_046875315b845ced1f973281aca3852c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c165187649ca5017ae8a14de35c16d83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41a09157ce6058086a8f1db02b73a201 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01880ccec5c6af446b85490f5d167472 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d403e8a6aa6cecaf4adedf0e926d0ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d0ec32a61b258af0097352aa5a89276 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3201f0124f79cc0fd09f2b3c9c75bce6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f95e56ddb2e685b45f8bba32348b62b2
date	200111
identifier	https://doi.org/10.1016/s0041-1345%2801%2902383-1 https://pubmed.ncbi.nlm.nih.gov/11750394
isPartOf	https://portal.issn.org/resource/ISSN/0041-1345 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/7835
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)
discusses	http://id.nlm.nih.gov/mesh/M0019074 http://id.nlm.nih.gov/mesh/M0011171 http://id.nlm.nih.gov/mesh/M0002065 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0005300 http://id.nlm.nih.gov/mesh/M0055297 http://id.nlm.nih.gov/mesh/M0025279
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016030Q000276 http://id.nlm.nih.gov/mesh/D007166Q000627 http://id.nlm.nih.gov/mesh/D012263Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D011241Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D001379Q000627 http://id.nlm.nih.gov/mesh/D003404Q000097 http://id.nlm.nih.gov/mesh/D016572Q000627 http://id.nlm.nih.gov/mesh/D019520 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D004359

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136129855 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861

Total number of triples: 51.